Cargando…
Urinary epidermal growth factor concentrations in various human malignancies.
We determined the concentrations of immunoreactive epidermal growth factor in the urine (U-irEGF) of 97 adult patients with various malignancies, including carcinomas of the urinary bladder, kidney, stomach, colon, rectum, breast, endometrium, uterine cervix, ovary, vagina, prostate, pancreas and th...
Autores principales: | Mattila, A. L., Saario, I., Viinikka, L., Ylikorkala, O., Perheentupa, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246428/ https://www.ncbi.nlm.nih.gov/pubmed/3258759 |
Ejemplares similares
-
Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.
por: Aitokallio-Tallberg, A., et al.
Publicado: (1989) -
Human vascular endothelial cells produce TNF-α after stimulation with proinflammatory cytokines
por: Ranta, V, et al.
Publicado: (1999) -
Enhancement of drug sensitivity of human malignancies by epidermal growth factor.
por: Kröning, R., et al.
Publicado: (1995) -
Epidermal growth factor receptor expression in urinary bladder cancer
por: Naik, Dayalu S. L., et al.
Publicado: (2011) -
The association of urinary epidermal growth factors with ADPKD disease severity and progression
por: Harskamp, Laura R, et al.
Publicado: (2023)